This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.

The USFDA inspection was conducted from March 17 to 21 at the Alembic Pharma API-III facility located at Karakhadi.

Amifampridine tablets are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 ...

Insolation Energy Limited have been awarded Letter of Award (LOA) by Rajasthan Renewable Energy Corporation Limited (RREC) ...

We are the problem when we would rather take the injection or the pill than make the lifestyle change. I am fortunate that I ...

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

A big dampener to Lupin’s plans would be the potential imposition of tariff on pharma products by the Trump government.

Despite the promising results, further research is needed before GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists ...

— Recommendations are independently chosen by our editors. Purchases you make through our links may earn us and our publishing partners a commission. Oh, to count the ways we love Brooklinen ...

In the last month, the price declined by 7.76%. ETMarkets.com Lupin share price: The company has launched its Rivaroxaban Tablets USP, 2.5mg, in the United States. The shares of Indian pharmaceutical ...

The approval is only for the 2.5mg tablet. Xarelto is also available in 10mg, 15mg, and 20mg tablets, as well as an oral suspension (1mg/mL), to treat various conditions. In a statement, the FDA noted ...

The pharma major has launched Rivaroxaban tablets (USP, 2.5 mg) in the United States after final approval of its Abbreviated New Drug Application from the US FDA. The drug is bioequivalent to Xarelto ...